Siam Bioscience
Berita
Penghantaran bekalan AstraZeneca untuk Asia Tenggara kini sedia
Bernama -
Siam Bioscience Co Ltd yang mengeluarkan AstraZeneca di Thailand akan menghasilkan kira-kira 180 juta dos tahun ini.
World
Thai-made AstraZeneca vaccines causing delays across Southeast Asia
Questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner.
World
Thai court orders removal of clips claiming king’s company ‘favoured’ in Covid-19 vaccine manufacture
Siam Bioscience is owned by King Maha Vajiralongkorn, and will supply the majority of doses despite an alleged lack of vaccine experience.